Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000425171 | SCV000522143 | uncertain significance | not provided | 2015-12-08 | criteria provided, single submitter | clinical testing | The P110H variant in the BBS1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The P110H variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The P110H variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret P110H as a variant of uncertain significance. |
| Dept Of Ophthalmology, |
RCV003889888 | SCV004707601 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
| Natera, |
RCV001833533 | SCV002094722 | uncertain significance | Bardet-Biedl syndrome 1 | 2020-02-25 | no assertion criteria provided | clinical testing |